Recording intelligenceAI-generated brief · check the source for context

Influenza NA Cross-Reactive Antibodies

1:31:47 recording · AUTO · 4 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Vincent presents a Cell Host & Microbe snippet on the evolution of antibody cross-reactivity to H5N1 neuraminidase from an N2-specific germline, first author Huibin Luv, corresponding authors Chris Mock and Nicholas Wu of the University of Illinois and the Chinese University of Hong Kong.5:43
  • The group screened plasma from 245 healthy people in Hong Kong collected between January and March 2020 and found anti-neuraminidase antibodies against H1N1, H3N2 and even H5N1, higher in younger age groups, which they attribute to imprinting by H1N1 infection.9:11
  • A phage display library yielded a single public clone, HB420, and its structure with an H3N2 neuraminidase shows the CDR H3 inserting into the enzyme's active site and mimicking sialic acid, while an N-linked glycosylation site acquired at residue 245 since 2016 blocks binding to recent human H3N2 strains.17:18
  • In mice, HB420 gave complete protection against H3N2 with 100% survival and minimal weight loss, 40% survival and a two-log lung titre reduction against a virus bearing the N1 of H5N1, and a LALA variant lost that protection, pointing to Fc effector functions rather than neutralisation.29:03
  • Steph then covers a Nature paper from May 2025 by Tamami Yoshida and Andrew Wang at Yale showing that the subfornical organ holds gut-derived CD4 T cells in mice and in human autopsy tissue, and that interferon gamma from those cells, along with CXCR6, is needed for normal feeding behaviour in a stress test.33:30

Brief overview

Two papers: a sialic-acid-mimicking antibody crosses flu neuraminidases, and gut-derived brain T cells shape feeding behaviour.

  1. Antibodies can mimic sialic acid to block neuraminidaseHB420's CDR H3 sits in the active site the way sialic acid would, and antibodies to HA do the same trick.
  2. Germline binds N2, hypermutation adds N1 cross-reactivityReverting all the somatic hypermutations left N2 binding intact but lost H5N1 binding, and heavy-chain changes did most of the work.
  3. Gut T cells reach the brain and change behaviourInterferon gamma-producing CD4 T cells enriched in the subfornical organ were required for normal latency to eat in the novelty suppressed feeding test.

Questions this recording answers

10 questions, each answered where it is said
Where in the healthy brain do T cells actually live?

Using immunohistochemistry in mice, they looked for CD4 T cells sitting in tissue away from blood vessels. These were relatively rare, but the subfornical organ stood out by numbers, with the choroid plexus second. Whole-brain clearing, 3D imaging and a CD4 fate-map tdTomato mouse supported the same conclusion.

Answered around 43:22
What behaviour changes when these brain T cells are missing?

The novelty-suppressed feeding test measures how long a hungry mouse waits before eating when the food sits in the middle of an open box, balancing hunger against anxiety. Mice lacking alpha-beta T cells, interferon gamma, TBET or CXCR6 showed delayed feeding, while IL-17-deficient mice did not.

Answered around 1:18:36
What evidence links these brain T cells to the gut microbiome?

Interferon gamma and IL-17 producing cells appeared in the brain right after weaning, and germ-free mice lacked them. Monocolonizing with segmented filamentous bacteria increased them, antibiotics depleted them, and blocking the trafficking receptors VLA4, LFA1 and the S1P receptor also kept these T cells out of the brain.

Answered around 1:02:08
Which neuraminidases does the antibody HB420 bind and block?

HB420 bound the H5N1 neuraminidase but none of the other group one NAs, and it did bind a subset of N2 NAs. It inhibited neuraminidase enzyme activity and blocked growth of an H1N1 virus, PR8, and an H3N2 virus, but not H5N1.

Answered around 15:24
How does an antibody shut down neuraminidase enzyme activity?

They solved the structure of HB420 bound to an H3N2 neuraminidase. The CDR H3 loop inserts directly into the enzyme's active site, which is how the antibody blocks activity. That site's conformation is similar in H3N2 and H5N1 neuraminidases, consistent with the antibody's cross-reactivity.

Answered around 17:18
Did the antibody protect mice against influenza challenge?

Mice got HB420 by IP injection either four hours before or 24 hours after intranasal infection. Against H3N2 it gave complete protection: 100% survival, minimal weight loss, reduced lung titers. Against a virus bearing the N1 of H5N1, protection was partial, 40% survival and a two-log titer reduction.

Answered around 29:03
Where does the cross-reactivity between N1 and N2 come from?

Reverting every somatic hypermutation left an antibody that still bound N2 neuraminidase but no longer H5N1. So the germline is already set up for N2, and the mutations added by affinity maturation, mainly in the heavy chain and outside the paratope, confer the N1 cross-reactivity.

Answered around 23:49
Why does this antibody fail against recent human H3N2 strains?

Since 2016 the circulating human H3N2 neuraminidase has carried an N-linked glycosylation site at amino acid 245. The structure shows the attached sugar blocking antibody binding, so HB420 does not bind recent H3N2 strains. Escape came from glycosylation occluding the epitope, not from amino acid changes in it.

Answered around 19:15
Why do younger people carry more antibodies against H5N1 neuraminidase?

Most people had neuraminidase antibodies against seasonal H1N1 and H3N2, and levels were higher in the younger age groups. The same held for antibodies against the H5N1 NA. They attribute this to imprinting by H1N1 infection in younger individuals, whose first exposure was around 2009.

Answered around 12:39
How does a non-neutralizing antibody still protect against infection?

HB420 does not neutralize in cell culture, so they suspected Fc-mediated effector functions. They made a LALA variant, which cannot bind Fc receptors or complement, and it no longer protected against viruses bearing the H5N1 neuraminidase. Effector functions are therefore probably the basis of the protection.

Answered around 30:02
Key Quote

“So the interesting part of this paper is they solve the structure of this antibody, HB420, to an H3N2NA, right?”

— Vincent Racaniello, Influenza NA Cross-Reactive Antibodies, at 17:18▶ listen at 17:18
Key Quote

“So they're painting this picture that in the gut, these T-cells can migrate to the brain.”

— Steph Lange, Influenza NA Cross-Reactive Antibodies, at 1:03:55▶ listen at 1:03:55
Key Quote

“So are you convinced that there are a specific subset of FTC cells in the parenchyma?”

— Vincent Racaniello, Influenza NA Cross-Reactive Antibodies, at 1:25:40▶ listen at 1:25:40
Key Quote

“I'm not convinced that the cells driving the behavior later in the paper are in that organ.”

— Steph Lange, Influenza NA Cross-Reactive Antibodies, at 1:25:57▶ listen at 1:25:57

Cite this

“Influenza NA Cross-Reactive Antibodies.” https://traffic.libsyn.com/secure/immune/Immune098.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/influenza-na-cross-reactive-antibodies.html.

Report this page
What is wrong with this page?